Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.
Community Guidelines: bit.ly/FMICommunityGuidelines
|
|
|
1,001-5,000 employees
View all Foundation Medicine employees
|
|
Biotechnology
|
|
150 Second Street, Cambridge, Massachusetts 02141, US
|
|
2010
|
|
Oncology, Precision Medicine, Next-Generation Sequencing, Molecular Information, Cancer Genomics, Comprehensive Genomic Profiling
|
Cindy Perettie is the CEO of Foundation Medicine. To contact Cindy Perettie email at [email protected].
The decision makers in Foundation Medicine are Allan Mohess, Amaya Gasco, Andrea Marengi, etc. Click to Find Foundation Medicine decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.